KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma. Issue 10 (3rd August 2020)

• Record Type: Journal Article
• Authors: Wei, Shi; Dai, Miaomiao; Zhang, Chi; Teng, Kai; Wang, Fengwei; Li, Hongbo; Sun, Weipeng; Feng, Zihao; Kang, Tiebang; Guan, Xinyuan; Xu, Ruihua; Cai, Muyan; Xie, Dan
• Is Part Of: Protein & cell. Volume 12:Issue 10(2021)
• Page Start: 788
• Page End: 809
• Publication Date: 2020-08-03
• Subjects: KIF2C -- HCC -- TBC1D7 -- mTORC1 signaling -- Wnt/β-catenin signaling; Proteins -- Periodicals; Cells -- Periodicals; Cytology -- Periodicals; 572.6
• DOI: 10.1007/s13238-020-00766-y
• Languages: English
• ISSNs: 1674-800X

Abstract

Abstract: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is the fourth-leading cause of cancer-related deaths worldwide. HCC is refractory to many standard cancer treatments and the prognosis is often poor, highlighting a pressing need to identify biomarkers of aggressiveness and potential targets for future treatments. Kinesin family member 2C (KIF2C) is reported to be highly expressed in several human tumors. Nevertheless, the molecular mechanisms underlying the role of KIF2C in tumor development and progression have not been investigated. In this study, we found that KIF2C expression was significantly upregulated in HCC, and that KIF2C up-regulation was associated with a poor prognosis. Utilizing both gain and loss of function assays, we showed that KIF2C promoted HCC cell proliferation, migration, invasion, and metastasis both in vitro and in vivo . Mechanistically, we identified TBC1D7 as a binding partner of KIF2C, and this interaction disrupts the formation of the TSC complex, resulting in the enhancement of mammalian target of rapamycin complex1 (mTORC1) signal transduction. Additionally, we found that KIF2C is a direct target of the Wnt/β-catenin pathway, and acts as a key factor in mediating the crosstalk between Wnt/β-catenin and mTORC1 signaling. Thus, the results of our study establish a link between Wnt/β-catenin and mTORC1 signaling, which highlights the potential of KIF2C as a therapeutic target for the treatment of HCC.